- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Weekly Investor Report
Japan Lifeline Co., Ltd. · Healthcare · Medical Devices
Mixed setup
The weekly trend is not active. Price is 13.0% above the Trend Line and sits at 93.8% of its 52-week range. The latest completed week returned 13.7%, after a 18.1% four-week move. The latest news-sentiment score is 47/100. Near-term considerations: price is close to its 52-week high.
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 13.0% above the Trend Line and sits at 93.8% of its 52-week range. The latest completed week returned 13.7%, after a 18.1% four-week move.
52-week price path
Price vs Trend Line and Fair ValueIs real participation confirming the move?
Latest weekly volume is 2.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price directionActivity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
12-week confirmation
No recent accumulation markers. 1 reversal markers.
Is performance persistent—and is the stock leading?
Performance is 18.1% over four weeks, 24.3% over 12 weeks, and 17.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Activity pressure vs relative leadership
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
No recent insider transactions are stored for this company.
Weighted news tone is neutral across 6 relevant articles.
0 positive · 5 neutral · 1 negativeActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signalWhat can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
Shape of recent returns
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
Four-week leaders
Four-week leaders
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Trend, activity pressure, participation, and risk combine to a 48/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.27; 1 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment47/100Weighted news tone is neutral across 6 relevant articles.
Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 1,570 JPY | 13.7% | 1,389 JPY | 1,262 JPY | 0.65 | -7.97 | 1.4M | Off |
| 24 Jul 2026 | 1,381 JPY | 1.0% | 1,387 JPY | 1,258 JPY | 0.17 | -19.84 | 540.8K | Off |
| 17 Jul 2026 | 1,368 JPY | 0.4% | 1,391 JPY | 1,255 JPY | -0.26 | -20.75 | 568.6K | Off |
| 10 Jul 2026 | 1,363 JPY | 2.6% | 1,397 JPY | 1,252 JPY | -0.60 | -26.82 | 702.5K | Off |
| 3 Jul 2026 | 1,329 JPY | 3.7% | 1,401 JPY | 1,249 JPY | -0.89 | -30.60 | 808.8K | Off |
| 26 Jun 2026 | 1,281 JPY | -0.4% | 1,405 JPY | 1,246 JPY | -1.14 | -33.47 | 137.4K | Off |
| 19 Jun 2026 | 1,286 JPY | -3.1% | 1,412 JPY | 1,243 JPY | -1.00 | -35.73 | 142.9K | Off |
| 12 Jun 2026 | 1,327 JPY | 0.4% | 1,417 JPY | 1,241 JPY | -0.92 | -29.31 | 218.4K | Off |
| 5 Jun 2026 | 1,322 JPY | -0.4% | 1,420 JPY | 1,239 JPY | -0.80 | -30.98 | 212.3K | Off |
| 29 May 2026 | 1,327 JPY | 2.4% | 1,422 JPY | 1,237 JPY | -0.75 | -31.26 | 1.1M | Off |
| 22 May 2026 | 1,296 JPY | 1.2% | 1,425 JPY | 1,234 JPY | -0.75 | -30.47 | 891.0K | Off |
| 15 May 2026 | 1,281 JPY | 1.4% | 1,431 JPY | 1,232 JPY | -0.77 | -29.89 | 1.5M | Off |
| 8 May 2026 | 1,263 JPY | -10.1% | 1,437 JPY | 1,230 JPY | -0.79 | -32.97 | 1.1M | Off |
| 1 May 2026 | 1,405 JPY | 2.2% | 1,443 JPY | 1,228 JPY | -0.69 | -22.24 | 660.0K | Off |
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.